Davide Leone & Partners Investment Co Ltd's Q4 2019 13F: 5 new positions, 4 exits
Form 13F-HR for the quarter ended Dec 31, 2019 · filed Feb 14, 2020 · 11 reported positions · accession 0001172661-20-000525
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | ALTABA INC (AABA) | 21.0% | — | −21.0 pts | −5.45M sh | −100% |
| Exited | CELGENE CORP (CELG) | 19.8% | — | −19.8 pts | −1.01M sh | −100% |
| New | MEDICINES CO (MDCO) | — | 16.4% | +16.4 pts | +1.15M sh | new |
| New | ALLERGAN PLC (AGN) | — | 16.3% | +16.3 pts | +506K sh | new |
| New | TIFFANY & CO NEW (TIF) | — | 12.9% | +12.9 pts | +571K sh | new |
| Exited | SPRINT CORPORATION (S) | 7.6% | — | −7.6 pts | −6.27M sh | −100% |
| New | HP INC (HPQ) | — | 6.9% | +6.9 pts | +2M sh | new |
| Exited | BIOGEN INC (BIIB) | 6.4% | — | −6.4 pts | −139K sh | −100% |
| New | QIAGEN NV (QGEN) | — | 5.8% | +5.8 pts | +1.01M sh | new |
| Reduced | BLACKBERRY LTD (BB) | 11.1% | 8.5% | −2.6 pts | −2.85M sh | −27% |
| Increased | VERTEX PHARMACEUTICALS INC (VRTX) | 2.6% | 4.6% | +2.0 pts | +47,800 sh | +62% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 99.9% of the equity book
Changes in the top 10 this quarter: MDCO entered · AGN entered · TIF entered · HPQ entered · QGEN entered · AABA left · CELG left · S left · BIIB left · BRK-A left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | MEDICINES CO (MDCO) | 0.0% | 16.4% | Entered the top 10 |
| 2 | ALLERGAN PLC (AGN) | 0.0% | 16.3% | Entered the top 10 |
| 3 | AT&T INC (T) | 16.9% | 14.9% | |
| 4 | TIFFANY & CO NEW (TIF) | 0.0% | 12.9% | Entered the top 10 |
| 5 | BLACKBERRY LTD (BB) | 11.1% | 8.5% | |
| 6 | ZAYO GROUP HLDGS INC (ZAYO) | 9.1% | 8.0% | |
| 7 | HP INC (HPQ) | 0.0% | 6.9% | Entered the top 10 |
| 8 | QIAGEN NV (QGEN) | 0.0% | 5.8% | Entered the top 10 |
| 9 | INCYTE CORP (INCY) | 5.5% | 5.5% | |
| 10 | VERTEX PHARMACEUTICALS INC (VRTX) | 2.6% | 4.6% | |
| — | ALTABA INC (AABA) | 21.0% | 0.0% | Left the top 10 |
| — | CELGENE CORP (CELG) | 19.8% | 0.0% | Left the top 10 |
| — | SPRINT CORPORATION (S) | 7.6% | 0.0% | Left the top 10 |
| — | BIOGEN INC (BIIB) | 6.4% | 0.0% | Left the top 10 |
| — | BERKSHIRE HATHAWAY INC DEL (BRK-A) | 0.1% | 0.1% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| New | MEDICINES CO (MDCO) | Call | 0 | 1M | $84.9M |
| New | HP INC (HPQ) | Put | 0 | 2M | $41.1M |
| New | SPRINT CORPORATION (S) | Call | 0 | 6.4M | $33.3M |